Safety and Tolerability, Pharmacokinetic, and Pharmacodynamic Study of ALXN1920 in Healthy Participants

Trial Identifier:	ALXN1920-HV-101
Sponsor:	Alexion Pharmaceuticals, Inc.
NCTID::	NCT05751642
Start Date:	April 2023
Primary Completion Date:	October 2023
Study Completion Date:	December 2023

Available Languages

For questions about your Trial Results Summary, please see Sponsor contact section within your Trial Results Summary.

No documents have been posted yet.

Stay informed about new Trial Results Summaries with our email notification service

Trial Locations

Country	Location
New Zealand, Auckland	Grafton, Auckland, New Zealand, 1010
NZ	Christchurch, NZ, 8011

Pharma Intelligence UK Limited is a company registered in England and Wales with company number 13787459 whose registered office is 3 More London Riverside, London SE1 2AQ.